ABSTRACT We have determined directly the effects of the inhibitory peptide phospholamban (PLB) on the rotational dynamics of the calcium pump (Ca-ATPase) of cardiac sarcoplasmic reticulum (SR). This was accomplished by comparing mouse ventricular SR, which has PLB levels similar to those found in other mammals, with mouse atrial SR, which is effectively devoid of PLB and thus has much higher (unregulated) calcium pump activity. To obtain sufficient quantities of atrial SR, we isolated the membranes from atrial tumor cells. We used time-resolved phosphorescence anisotropy of an erythrosin isothiocyanate label attached selectively and rigidly to the Ca-ATPase, to detect the microsecond rotational motion of the Ca-ATPase in the two preparations. The time-resolved phosphorescence anisotropy decays of both preparations at 250C were multi-exponential, because of the presence of different oligomeric species. The rotational correlation times for the different oligomers were similar for the two preparations, but the total decay amplitude was substantially greater for atrial tumor SR, indicating that a smaller fraction of the Ca-ATPase molecules exists as large aggregates. Phosphorylation of PLB in ventricular SR decreased the population of large-scale Ca-ATPase aggregates to a level similar to that of atrial tumor SR. Lipid chain mobility (fluidity), detected by electron paramagnetic resonance of stearic acid spin labels, was very similar in the two preparations, indicating that the higher protein mobility in atrial tumor SR is not due to higher lipid fluidity. We conclude that PLB inhibits by inducing Ca-ATPase lateral aggregation, which can be relieved either by phosphorylating or removing PLB.
INTRODUCTION
The Ca-ATPase of the sarcoplasmic reticulum (SR) is a 110-kDa transmembrane protein, which couples the hydrolysis of ATP to the active transport of calcium ions into the SR lumen against a concentration gradient (reviewed by Inesi, 1985) . In cardiac SR, the Ca-ATPase is regulated by phospholamban (PLB), which is not found in fast-twitch skeletal SR (Kirchberger and Tada, 1976; Tada and Katz, 1982; Jorgensen and Jones, 1986; Voss et al., 1994) . Phospholamban is an amphipathic, 52-residue protein, with a hydrophilic (cytoplasmic) phosphorylation domain and a hydrophobic (transmembrane) domain, which probably exists as a homopentamer Simmerman et al., 1986; Fujii et al., 1987) . Phosphorylation of PLB results in a stimulation of ATPase activity and calcium uptake at submicromolar [Ca21] (Davis et al., 1983; Tada et al., 1988) . Studies using reconstitution of the Ca-ATPase and PLB (Inui et al., 1986) , proteolytic cleavage of the cytoplasmic portion of PLB (Kirchberger et al., 1986) , and co-expression of the Ca-ATPase and PLB in COS-1 cells (Fujii et al., 1990; Toyofuku et al., 1993) and Sf21 insect cells (Autry et al., 1994) provide strong evidence that unphosphorylated PLB is a CaATPase inhibitor at low [Ca2"]. Evidence has been provided that PLB's inhibitory action involves 1) interaction between the cytoplasmic domain of PLB and sites in the phosphorylation domain and nucleotide-binding hinge domain of the Ca-ATPase (Toyofuku et al., 1993) , and 2) electrostatic interaction between the basic (positively charged) residues of PLB's cytoplasmic domain and negatively charged residues in the stalk region of the Ca-ATPase (Voss et al., 1994; Tada et al., 1989) . The regulation of the Ca-ATPase by PLB shows an electrostatic dependence consistent with a major involvement of charged residues (Xu and Kirchberger, 1989; Chiesi and Schwaller, 1989) .
Extensive spectroscopic studies of the Ca-ATPase in rabbit skeletal SR have shown that the molecular dynamics of the enzyme and its associated lipids are important for the Ca-ATPase mechanism (Thomas and Mahaney, 1993; Thomas and Karon, 1994) . For example, decreased ATPase activity results from perturbations that decrease microsecond protein rotational motion detected by saturation transfer electron paramagnetic resonance (ST-EPR) (Squier and Thomas, 1988; Squier et al., 1988a, b; Mahaney and Thomas, 1991) . Similarly, time-resolved phosphorescence anisotropy (TPA) measurements show a strong correlation between conditions that inhibit (or increase) Ca-ATPase activity and those that promote protein association (dissociation), including some perturbations that have negligible effects on lipid fluidity (Birmachu and Thomas, 1990; Voss et al., 1991; Karon and Thomas, 1993) .
We have previously compared Ca-ATPase rotational dynamics in dog cardiac and rabbit skeletal SR (Birmachu et al., 1993) . The rotational mobility of the enzyme in cardiac SR was much more restricted than the enzyme in skeletal SR. Our results indicated that the decreased mobility of the cardiac enzyme could not be attributed to differences in lipid composition or bilayer fluidity, but was almost certainly due to a large fraction of the enzyme in cardiac SR associated in large-scale aggregates. Based on previous studies correlating changes in Ca-ATPase aggregation with changes in CaATPase mobility and activity (reviewed by Thomas and Mahaney, 1993) , the high level of protein association and lower Ca-ATPase activity in cardiac SR relative to skeletal SR was attributed to the presence of PLB in the cardiac membrane (Birmachu et al., 1993) . We have investigated recently the Ca-ATPase dynamics in cardiac SR as a function of PLB phosphorylation and [Ca2"] (Voss et al., 1994) . This work showed that the cardiac Ca-ATPase is highly aggregated in its inhibited state, when PLB is unphosphorylated at submicromolar Ca2", but stimulation of the Ca-ATPase, either by PLB phosphorylation or micromolar [Ca2" ], correlates with enzyme dissociation from large aggregates.
To test directly the functional and physical effects of PLB on the Ca-ATPase, it is desirable to study the cardiac enzyme in its native membrane in the presence and absence of PLB. Jones and Field (1993) have reported that cardiac SR vesicles isolated from AT-1 cardiomyocytes are essentially devoid of PLB, whereas mouse ventricular SR vesicles contain high levels of PLB. AT-1 cardiomyocytes are a transplantable tumor lineage derived from transgenic mice expressing the SV40 large T antigen (Field, 1988) . Large amounts of mouse atrial SR vesicles sufficient for direct physical study are easily isolated from these subcutaneously growing tumors. Therefore, in the present study, we have used TPA to characterize the microsecond protein rotational motion of the Ca-ATPase in mouse ventricular SR and mouse atrial tumor SR (obtained from AT-1 cells), to compare directly the enzyme mobility in these two systems, and thus to determine directly the effects of PLB on Ca-ATPase dynamics and protein-protein association. Because protein rotational diffusion can be affected either by protein structure or by lipid viscosity (Saffman and Delbruck, 1975) , we have also used EPR spectroscopy to measure lipid chain rotational dynamics in the two systems. The absence of PLB in atrial SR and the presence of PLB in ventricular SR allows for the precise determination of the effects of PLB on the molecular dynamics of the cardiac Ca-ATPase of the same isoform in the same membrane from the same species.
MATERIALS AND METHODS Reagents and solutions
Erythrosin 5-isothiocyanate (ErITC) was obtained from Molecular Probes Inc. (Eugene, OR) and was stored in DMF at -70°C. Glucose oxidase type IX, catalase, glucose, and ATP were obtained from Sigma Chemical Co. (St.
Louis, MO). Calyculin A (phosphatase inhibitor) was obtained from LC Services Corporation (Woburn, MA). Fatty acid spin labels were obtained from Aldrich Chemical Company (Milwaukee, WI). All other reagents were of the highest purity available. Biochemical and spectroscopic measurements were carried out in a solution containing 60 mM KCl, 1 mM MgCl2, 10 mM EGTA, 2 mM CaCl2 (0.1 ,uM free Ca2") (Fabiato, 1988) , 50 mM
SR Vesicle isolation
The mouse atrial tumor and ventricular SR membranes used in this study were identical to those isolated and characterized by Jones and Field (1993) . The isolation procedure was based on Jones and Cala (1981) (1985) using an 8% slab gel, 1.5 mm thick. The specificity of ErITC labeling of the Ca-ATPase was confirmed using quantitative analysis of the photographic negatives of SDS gels of SR labeled with FITC. Gels were illuminated with a UV lamp, and photographs were taken through a 550-nm cutoff filter, before staining the gels with Coomassie blue, as described previously (Birmachu et al., 1993) . FITC was used in the label specificity studies in place of ErITC because FITC fluoresces much more intensely than ErITC, allowing visualization of the label distribution in the fluorescent photographs. ErITC is nearly identical chemically to FITC, and inhibits both the rabbit skeletal and dog cardiac isoforms of the Ca-ATPase in a manner similar to that of FITC (Birmachu et al., 1993) , strongly suggesting that ErITC derivatizes primarily the FITC site of the enzyme. Immunoblotting was performed as described by Jones and Field (1993) using the Ca-ATPase monoclonal antibody 2A7-A1 and the PLB monoclonal antibody 2D12. Antibody-reacting bands were detected by autoradiography after incubation with l"I-labeled protein A (Manalan and Jones, 1982) (Fig. 1) .
Quantitative immunoblotting was used in combination with SDS gel electrophoresis to determine the relative ratio of PLB to Ca-ATPase in the two SR preparations (Fig. 1 ). The two preparations contain similar amounts of Ca-ATPase (ventricular SR/atrial tumor = 1.13). However, the ventricular SR preparation contains 7 times more PLB than does the atrial tumor SR preparation, so the PLB/Ca-ATPase ratio is 6.2 times greater in mouse ventricular SR than in mouse atrial tumor SR.
Labeling and sample preparation
For phosphorescence experiments, the SR vesicles were labeled with ErITC, as described previously (Birmachu and Thomas, 1990 ). This procedure specifically labels the Ca-ATPase in both skeletal and cardiac SR (Birmachu et al., 1993 The stoichiometry of labeling was 0.8 ± 0.1 moles of ErITC bound per ATPase in both the atrial and ventricular SR, determined by measuring the absorbance at 536 nm of an aliquot of ErITC-SR in the presence of 2% deoxycholate, using e536 = 80,000 M`cm-' for the Ca-ATPase-bound ErITC (Birmachu and Thomas, 1990) and assuming a molecular mass of 110 kDa for the Ca-ATPase. Densitometer scans of the fluorescent and Coomassie blue-stained SDS polyacrylamide gels ( Fig. 1) showed that the probe binds specifically to the Ca-ATPase in both the atrial and ventricular SR, because 68 ± 3 and 65 ± 3% of the fluorescence intensity was associated with the 110-kDa ATPase band in both atrial and ventricular SR, respectively. The remaining fluorescence intensity in each sample was localized at the top of the gel, which we determined by Western blot analysis (not shown) was Ca-ATPase that did not enter the gel. The specificity of labeling, therefore, was similar to that obtained for rabbit skeletal ErITC-Ca-ATPase, where the label reacts with >90% specificity with Lys 515 in the Ca-ATPase (Mitchinson et al., 1982; Birmachu et al., 1993) , and the extent of labeling was nearly identical in the mouse atrial tumor SR and mouse ventricular SR preparations.
Lipid hydrocarbon chain rotational mobility was measured with stearic acid spin labels containing the nitroxide group at either the C-5 position (5-SASL) or the C-16 position (16-SASL). Before incorporation into SR, these labels were diluted from a 0.1 M dimethylformamide stock solution into ethanol (because of the greater miscibility of ethanol with water). A sufficient amount of label was added to SR to provide a ratio of 1 label per 150 phospholipids, while keeping the final ethanol concentration in all samples below 1%. The labeled SR was vortexed well, diluted by a factor of 10 with experimental buffer, and pelleted in a low-speed table-top centrifuge to remove any unbound label. The pellet was resuspended in the Phospholamban phosphorylation
Before our experiments, the SR membranes were treated with type 2A protein phosphatase at room temperature for 30 min to ensure complete dephosphorylation of PLB (Jones and Field, 1993) . PLB phosphorylation was performed just before gel electrophoresis and TPA data collection. SR vesicles were incubated with 40 ,ug/ml of the catalytic subunit of protein kinase-A in a buffer containing 50 mM Tris-HCl, 0.1 mM DTT, 2 mM MgCl2, 0.75 mM ATP containing 2-3 mCi/ml [y-32P]ATP, 50 nM phosphatase inhibitor calyculin A, pH 7.0, at 30°C. After a 3-min incubation, the sample was immediately centrifuged at 100,000 X gm. for 5 min at 4°C, and the phosphorylated SR vesicles were resuspended in ice-cold 30 mM MOPS, 250 mM sucrose, 50 nM calyculin A, pH 7.0, and kept on ice. Control SR was treated in the same way, except that protein kinase-A was omitted.
The specificity of PLB phosphorylation was measured by autoradiography of SDS gels of sample aliquots taken directly from the PLB phosphorylation medium and spectroscopy samples (Voss et al., 1994) . Fig. 2 indicates that most of the phosphorylation was localized to the PLB protein. Lanes 2 and 3 are mouse ventricular SR, and lanes 4 and 5 are mouse atrial SR. PLB was phosphorylated as described in Materials and Methods. The ± symbols indicate whether the membrane samples were boiled in SDS before electrophoresis. PLBH and PLBL denote the pentameric and monomeric forms of PLB, respectively. samples analyzed before (denoted by -in Fig. 2 ) and after (denoted by + in Fig. 2 Time-resolved phosphorescence anisotropy spectroscopy
The experimental and analytical procedures for time-resolved phosphorescence anisotropy (TPA) of skeletal and cardiac SR have been described in detail previously (Birmachu and Thomas, 1990; Birmachu et al., 1993) . Before TPA data collection, oxygen was removed enzymatically from the labeled sample (0.2 to 0.4 mg SR/ml) in a sealed 1-cm quartz cuvette with 100 ,ug/ml glucose oxidase, 15 jig/ml catalase, and 5 mg/ml glucose for 10-15 min, as described previously (Birmachu et al., 1993) . The spectrometer used to obtain TPA decays was described previously (Ludescher and Thomas, 1988) . The phosphorescence anisotropy (r) is given by r(t) = I + 2GI,' (1) where I, and Ih are the time-dependent decays of the phosphorescence intensities observed through polarizers oriented parallel and perpendicular, respectively, to the vertically polarized excitation pulse. G is an instrumental correction factor determined from the apparent anisotropy of the free dye in solution, for which the corrected anisotropy is zero. TPA decays of ErITClabeled Ca-ATPase were detected and signal-averaged for 20 loops, each consisting of 2000 acquisitions of Qt) and 2000 acquisitions of 4ht). The laser repetition rate was 100-200 Hz, so a typical experiment lasted about 10 min.
TPA decays were analyzed as reported previously (Birmachu and Thomas, 1990) , using a nonlinear least-squares fit to a sum of exponentials plus a constant:
where 4, are rotational correlation times, Ai are the normalized amplitudes (r/rj), A. is the normalized residual anisotropy (rjrj), and ro is the initial anisotropy (r(0) = r. = :r; + r ). The goodness-of-fit for the anisotropy decays was evaluated primarily from plots of the residuals (the difference between the measured and the calculated values), and also from x2 values. The number of exponentials (n in Eq. 2) was increased until no further improvement was observed. In the present study, the best fit for anisotropy decays was consistently for n = 3. This does not necessarily imply that there are precisely three components present. It is quite possible that either 1) there are more than three species but signal/noise is not sufficient to resolve them, or 2) there is a continuum of exponential components. The conclusions of the present study would not be altered by considering these other alternatives.
It has been shown previously (Birmachu and Thomas, 1990; Mersol et al., 1995) that the TPA of ErITC-SR is dominated by the uniaxial rotation of the labeled Ca-ATPase about an axis normal to the bilayer. For this model, each different rotational diffusion coefficient should give rise to a biexponential decay component (Kinosita et al., 1984) (reviewed by Thomas, 1986 ), but it has been shown that a single-exponential approximation is sufficient to describe the decay for each rotating species in ErITC-SR (Birmachu and Thomas, 1990; Mersol et al., 1995) . As long as the probe orientation relative to the protein is the same for all proteins, the mole fraction (ft) of probes in the ith rotating species, having rotational correlation time 4 is given by A.
(Ix-A 'M)
wheref, is the fraction of probes (i.e., proteins) that are immobile on the time scale ofthe experiment (Birmachu et al., 1993) . A. is the normalized residual anisotropy of a reference sample for whichf, = 0 and describes the extent to which the probe's motion is restricted in angular range, due to the fixed angles Oma. and Om, of the probe's absorption and emission transition moments relative to the membrane normal:
where P2(x) = (3x2 -1)/2, and Oae is the angle between the absorption and emission transition moments (Lipari and Szabo, 1980) . A.0 has been shown to be 0.22 for ErITC-Ca-ATPase in skeletal SR (Birmachu and Thomas, 1990) and is assumed to be the same for cardiac SR (Birmachu et al., 1993) .
If this value of A... is an underestimate, it would result in an underestimate of f and an overestimate off, (Eq. 3).
The rotational diffusion coefficient (D.) for uniaxial rotation of a cylindrical membrane protein can be expressed as a function of the membrane lipid viscosity (ij), the temperature (T), and the effective radius (a) of the portion of the protein in the bilayer (Saffman and Delbruck, 1975) :
where h is the thickness of the hydrocarbon phase of the lipid bilayer. Thus, the rotational correlation time (inversely proportional to the diffusion coefficient), should be proportional to the lipid viscosity (inverse of fluidity) and to the intramembrane cross-sectional area (na2) of the rotating protein.
This theory relating protein size and lipid fluidity to protein rotational mobility is supported by previous studies on the Ca-ATPase as measured by both ST-EPR (Squier et al., 1988a, b) and phosphorescence anisotropy (Birmachu and Thomas, 1990) , which showed that the microsecond rotational motions of the SR probes used in those studies ( Thomas, 1990) . Thus, the distribution of oligomeric species is given by the fractionsf (Eq. 3). The fraction of proteins in immobile species fl, determined from the residual anisotropy A., thus corresponds to protein aggregates so large that they undergo little or no rotational diffusion in the 1-ms time window of the TPA experiment. Because the correlation time of a Ca-ATPase monomer or dimer is on the order of 5-30 p,s, these immobile aggregates must contain more than 10 Ca-ATPase molecules (Birmachu and Thomas, 1990; Voss et al., 1991; Birmachu et al., 1993) .
EPR spectroscopy EPR spectra were acquired with a Bruker ESP-300 spectrometer equipped with a Bruker ER4201 cavity, and digitized with the spectrometer's built-in microcomputer using Bruker OS-9-compatible ESP 1620 spectral acquisition software. Spectra were downloaded to an IBM-compatible microcomputer and analyzed with software developed in our laboratory by R. L. H. Bennett. EPR spectra were obtained using 100-kHz field modulation (with a peak-to-peak modulation amplitude of 2 Gauss), with a microwave field intensity (Hj) of 0.14 Gauss (Squier and Thomas, 1986) . Sample temperature was controlled to within 0.5°C with a Bruker ER 4111VT-1003 variable temperature controller. Sample temperature was monitored with a Sensortek Bat-21 digital thermometer using an IT-21 thermocouple probe inserted into the top of the sample capillary, such that it did not interfere with spectral acquisition.
EPR spectra were analyzed by measuring the inner (2T1) and outer (2Tj1) spectral splittings, which are sensitive mainly to the label's rotational amplitude, and the half-width at half-height of the low-field peak (AL), which is sensitive mainly to the label's rate of motion (Fig. 3) . The effective order parameter (S) for the hydrocarbon chain mobility of 5-and 16-SASL was evaluated from the splittings by two equivalent methods. The 5-SASL spectra had well resolved extrema, such that both 2T1 and 2TIcould be measured, allowing the use of the expression (Gaffney, 1976) :
T 2(T; + C) where C = 1.4 -0.053(2T7j -2T1). For 16-SASL spectra, Eq. 6 is not applicable for calculating the effective order parameter. Therefore, 16-SASL order parameters were determined by the expression (Gaffney, 1976) :
where To is the isotropic hyperfine splitting constant in the absence of anisotropic effects and TL is the minimum principal value of the hyperfine constant for an axially symmetric system such as a lipid bilayer. The values of T. and Tj used in this study were 14.3 and 6.3 G, respectively, as determined previously (Squier and Thomas, 1989) . The effective lipid fluidity (T/i1) was calculated using the order parameter (S) obtained from the 5-or 16-SASL spectra using the following empirical expression (Squier et al., 1988a) :
where T is the absolute temperature and q is the depth-dependent bilayer viscosity in centipoise. This fluidity parameter, along with Eq. 5, can be used to determine whether differences in Ca-ATPase rotational mobility in atrial versus ventricular SR are due to differences in bilayer fluidity (T/fr) or to changes in the size (aggregation state) of the rotating proteins (Mahaney and Thomas, 1991; Voss et al., 1991) . .3-0.6 mg/ml at 25°C in 60 mM KCl, 1 mM MgCl2, 50 mM MOPS, pH 7.0). Overlayed on the decay curves are the fits to the decays using Eq. 2 and the parameters given in Table 2 .
RESULTS

Phosphorescence emission decay
The decay of the total unpolarized phosphorescence emission intensity of mouse atrial tumor SR and mouse ventricular SR labeled with ErITC was multiexponential ( Table 1 ). The emission decay from both preparations was best fit by a fourexponential function, with no improvement in the residual or X2 of the fit by increasing n to 5. The similarities of each lifetime and amplitude in each system is consistent with our finding the same specificity of labeling determined from gel electrophoresis. Thus, differences in the anisotropy decay are not attributed to different lifetime components or component amplitudes.
Phosphorescence anisotropy
The TPA decays of ErITC-Ca-ATPase in the two SR preparations are shown in Fig. 3 . As shown previously for the TPA decay of ErITC-labeled Ca-ATPase (Birmachu and Thomas, 1990) , the TPA decays for ErITC-mouse ventricular SR were best fit to a three-exponential decay function ( Table 2 ). The Ca-ATPase in both atrial tumor and ventricular SR exhibits rotational correlation times that are identical within experimental error ( 
Lipid chain dynamics
To determine whether higher membrane viscosity could account for the decreased Ca-ATPase rotational mobility in ventricular SR, we measured the lipid hydrocarbon chain mobility in mouse ventricular SR and mouse atrial tumor SR using stearic acid spin labels. 5-SASL was used to measure chain dynamics near the head group region of the bilayer, and 16-SASL was used to measure chain dynamics near the central region of the bilayer. Typical EPR spectra obtained from each probe in mouse ventricular SR and mouse atrial tumor SR are shown in Fig. 4 . The spectra were characterized by the outer splitting, 2T(j, inner splitting, 2T'L, the outer halfwidth at half-height of the low-field peak, AL, the order parameter of the label, S, and the bilayer fluidity at the label depth, T/fq (Table 3) . Because sample limitations, each experiment was performed only once, and typical errors in the spectral parameters (estimated from Mahaney and Mahaney et al., 1992) are listed in the legend of Table 3 . The mobility of the lipid hydrocarbon chains in the mouse atrial tumor SR bilayer is only slightly restricted relative to that of the mouse ventricular SR bilayer, as evidenced by the very small changes in the splittings of the 5-and 16-SASL spectra (-1 and 3% change in 2T(j and 27L, respectively, for each label). These small differences in splittings translated into slightly larger reductions of the order parameter (3.2 and 3.8% for the 5-and 16-SASL spectra, respectively) and fluidity (7.5 and 5.4% for the 5-and 16-SASL spectra, respectively) in mouse atrial tumor SR relative to mouse ventricular SR. Given the estimated limits of error on each of the spectral parameters, these differences may not be significant, such that there is no difference in the lipid hydrocarbon chain mobility in the two bilayers. Nevertheless, because the fluidity of the mouse atrial tumor SR bilayer is slightly reduced relative to that of the mouse ventricular SR bilayer, the increased Ca-ATPase mobility in mouse atrial tumor SR versus mouse ventricular SR cannot be attributed to differences in lipid fluidity.
DISCUSSION
Summary of results
We present here the first direct comparative study of the Ca-ATPase rotational dynamics in native cardiac SR membranes with and without the regulatory protein PLB, designed to elucidate the underlying mechanism for the regulation of the cardiac Ca-ATPase. The Ca-ATPase of mouse ventricular SR, which contains PLB, and mouse atrial tumor SR, which is essentially devoid of PLB, was labeled with ErITC with similar specificity in both SR preparations. TPA measurements showed that ventricular Ca-ATPase is less rotationally mobile than the atrial Ca-ATPase. The difference in the motional properties of the Ca-ATPases in the two SR preparations is due primarily to differences in the amplitudes of motion, especially the limiting anisotropy A,,, not in the rate (1/0) of motion. Conventional EPR spectra of spinlabeled fatty acids showed no significant difference in lipid bilayer fluidity in the two SR preparations.
Lipid dynamics
From the theory of transmembrane protein rotational mobility (Saffman and Delbriick, 1975 ) (Eq. 5 in the present study), the observed differences in Ca-ATPase mobility could be due to differences in either 1) membrane viscosity (71 in Eq. 5), or 2) the average cross sectional area (nra2 in Eq. 5) of the rotating units in the plane of the membrane (i.e., an increased state of protein association). The strong influence of SR membrane fluidity on Ca-ATPase rotational mobility has been demonstrated previously (Bigelow and Thomas, 1987; Squier et al., 1988a) . Therefore, we measured the lipid chain dynamics (Fig. 4, Table 3 ) to determine (Table 3 ). Because Eq. 5 predicts the rotational diffusion coefficient (Di) of a membrane protein to be directly proportional to lipid fluidity (Th1y), the large differences in the Ca-ATPase rotational dynamics cannot be explained by the negligible differences in membrane viscosity. Thus, the difference in protein dynamics most likely results from the differences in protein associations.
Protein dynamics
The best fit using Eq. 2 to the TPA decays of both ventricular and atrial ErITC-SR was achieved with n = 3, consistent with previous results from this laboratory (Voss et al., 1994; Birmachu et al., 1993; Birmachu and Thomas, 1990; Voss et al., 1991) . It has been shown previously that the TPA decay of ErITC-SR reports primarily the uniaxial diffusion of the Ca-ATPase; that is, the rotation of the protein about the membrane normal (Cherry, 1978) , as predicted by Eqs. 3-5 (Birmachu and Thomas, 1990 Thomas, 1990) . The greatest ambiguity is with 41, which could be assigned as a resolved monomer or segmental motion of the protein backbone.
The most striking difference in the phosphorescence anisotropy decay between ventricular and atrial tumor SR ATPases is the difference in the magnitude of A., representative of the species whose motion is too slow to observe on the time scale of the TPA experiment. There are three possible explanations for this difference. First, the Ca-ATPase in mouse ventricular SR could have a smaller amplitude of wobble (cone angle 0) for rotation about axes in the membrane plane, but this is unlikely, because the rotation of the skeletal Ca-ATPase is dominated by uniaxial diffusion, not wobble (Birmachu and Thomas, 1990) . Second, the two systems could differ in the orientation of the probe relative to the protein's axis of rotation (the membrane normal) in uniaxial diffusion (Eq. 4). Although this cannot be ruled out, it is unlikely, because 1) the enzymes are of identical sequence, predicting identical topology, 2) a previous comparison of cardiac and skeletal SR (which lacks PLB) using ST-EPR of a probe attached to a different site gives qualitatively the same answer in terms of overall mobility, and 3) the difference in A. can be explained more simply without invoking this conformational change. The third and most likely explanation for the larger A. in ventricular SR is an increasedfraction ofproteins rotating on a time scale slower than the window of spectroscopic detection (in this case, 1 ms). As discussed earlier, this cannot be due to greater lipid viscosity (ri in Eq. 5) in mouse ventricular SR, which would need to be larger by a factor of 10 or more in a discrete domain of the bilayer. This is clearly not consistent with the V1 EPR measurements of lipid fluidity in ventricular and atrial tumor SR (Fig. 4, Table 3 ). Thus, the largerA. in mouse ventricular SR is almost certainly due to a very large increase in the cross sectional area (-ra2 in Eq. 5) of the rotating body in the plane of the membrane, i.e., to large-scale lateral association of the protein.
The residual anisotropy value (A.) can be used to estimate the fraction of Ca-ATPase that is highly immobilized in large aggregates (Eq. 3, see Materials and Methods). We assume that these large aggregates are completely immobilized in our 1-ms time window of observation, such that their residual anisotropy is equal to their initial anisotropy (A. = Ao = 1).
We also assume that enzymes not in large aggregates have the same A. (0.22) as observed in skeletal SR (Birmachu and Thomas, 1990) . Thus, the observed residual anisotropy in mouse ventricular (A,. = 0.78), phosphorylated ventricular (Ax. = 0.69) and atrial (Ax. = 0.66) SR, is consistent with 72, 60, and 56% of the enzyme in a highly aggregated state, respectively. Consistent with the hypothesis that increased Ca-ATPase association correlates with decreased enzyme activity, both the absence of PLB in atrial SR or phosphorylation ofPLB in ventricular SR results in activation of calcium transport (Jones and Field, 1993) and a decrease in the fraction of large-scale Ca-ATPase aggregates. The high level of Ca-ATPase immobilization in mouse cardiac SR that is independent of the presence of PLB can most likely be attributed to the fraction of highly aggregated Ca-ATPase in this system (see Labeling and Sample Preparation in Materials and Methods). The nature of the aggregation and the likely functional manifestations warrant further study.
Relationship to other work We have demonstrated previously that nearly half of the CaATPase in dog cardiac SR exists as large-scale aggregates, compared with effectively no large-scale Ca-ATPase aggregates in fast-twitch skeletal SR (Birmachu et al., 1993) . We have also shown that phosphorylation of PLB in dog cardiac SR promotes Ca-ATPase disaggregation and increases Catransport rates (Voss et al., 1994) . In the present study, we find that the Ca-ATPase of mouse ventricular SR is less rotationally mobile than the Ca-ATPase of mouse atrial tumor SR, because of a larger fraction of ATPases in large-scale aggregates. The primary distinction in protein components between mouse ventricular and atrial SR is the absence of PLB in the latter. Thus, inhibition of Ca-ATPase activity by PLB strongly correlates with a PLB-dependent increase in the level of large-scale Ca-ATPase association.
CONCLUSION
We have proposed previously a model for the physical basis of PLB inhibition of the Ca-ATPase (Voss et al., 1994; Birmachu et al., 1993) . In this model, the basic cytoplasmic charges of a phospholamban pentamer interact with two or more Ca-ATPase molecules via the acidic stalk region. Based on previous model studies of the interaction of a basic amphipathic peptide with the Ca-ATPase (Voss et al., 1991; Mahaney and Thomas, 1991; Mahaney et al., 1992) , such interaction would lead to a large network of immobilized Ca-ATPase proteins, consistent with our spectroscopic results. The Ca-ATPase in atrial SR, lacking phospholamban, would therefore display greater mobility, also consistent with our spectroscopic results (Fig. 5) . Further work will be needed to determine the molecular mechanism whereby 1) PLB aggregates the Ca-ATPase in a phosphorylationdependent manner, and 2) this aggregation inhibits the Ca-ATPase at low calcium.
